APPIAN CORP
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
APPN$51.60-4.5%Stored close · as of Nov 6, 2026
Contents
Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024
CONSOLIDATED BALANCE SHEETS
(in thousands, except par value and share data)
| As of | ||
|---|---|---|
| September 30, 2025 | December 31, 2024 | |
| (unaudited) | ||
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $125,249 | $118,552 |
| Short-term investments and marketable securities | 66,312 | 41,308 |
| Accounts receivable, net of allowance of $2,862 and $3,396, respectively | 172,615 | 195,069 |
| Deferred commissions, current | 34,131 | 36,630 |
| Prepaid expenses and other current assets | 41,104 | 43,984 |
| Total current assets | 439,411 | 435,543 |
| Property and equipment, net of accumulated depreciation of $38,789 and $32,142, respectively | 33,168 | 37,109 |
| Goodwill | 28,833 | 25,555 |
| Intangible assets, net of accumulated amortization of $6,985 and $5,341, respectively | 1,567 | 2,240 |
| Right-of-use assets for operating leases | 29,110 | 31,081 |
| Deferred commissions, net of current portion | 59,395 | 60,540 |
| Deferred tax assets | 5,144 | 4,129 |
| Other assets | 15,107 | 24,842 |
| Total assets | $611,735 | $621,039 |
| Liabilities and Stockholders’ Deficit | ||
| Current liabilities | ||
| Accounts payable | $8,605 | $4,322 |
| Accrued expenses | 20,082 | 11,388 |
| Accrued compensation and related benefits | 38,677 | 34,223 |
| Deferred revenue | 275,449 | 281,760 |
| Debt | 12,098 | 9,598 |
| Operating lease liabilities | 13,110 | 12,378 |
| Other current liabilities | 2,105 | 1,087 |
| Total current liabilities | 370,126 | 354,756 |
| Long-term debt | 233,627 | 240,826 |
| Non-current operating lease liabilities | 47,769 | 52,189 |
| Deferred revenue, non-current | 8,322 | 5,477 |
| Other non-current liabilities | 435 | 431 |
| Total liabilities | 660,279 | 653,679 |
| Stockholders’ deficit | ||
| Class A common stock—par value $0.0001; 500,000,000 shares authorized as of September 30, 2025 and December 31, 2024 and 43,369,326 and 42,938,701 shares issued as of September 30, 2025 and December 31, 2024, respectively | 4 | 4 |
| Class B common stock—par value $0.0001; 100,000,000 shares authorized as of September 30, 2025 and December 31, 2024 and 31,088,085 and 31,090,085 shares issued as of September 30, 2025 and December 31, 2024, respectively | 3 | 3 |
| Treasury stock at cost, 639,751 shares as of September 30, 2025 | (20,000) | — |
| Additional paid-in capital | 612,488 | 591,281 |
| Accumulated other comprehensive loss | (35,221) | (11,774) |
| Accumulated deficit | (605,818) | (612,154) |
| Total stockholders’ deficit | (48,544) | (32,640) |
| Total liabilities and stockholders’ deficit | $611,735 | $621,039 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.